Statements (65)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:genus
|
gptkbp:bfsLayer |
4
|
gptkbp:bfsParent |
gptkb:West_Nile_virus
|
gptkbp:caused_by |
gptkb:psychologist
hemorrhagic fever |
gptkbp:communication |
mosquitoes
|
gptkbp:contains |
gptkb:Zika_virus
gptkb:healthcare_organization gptkb:Japanese_encephalitis_virus gptkb:West_Nile_virus gptkb:Yellow_fever_virus |
gptkbp:first_described_by |
1940s
|
gptkbp:focuses_on |
public awareness campaigns
scientific conferences epidemiological research |
https://www.w3.org/2000/01/rdf-schema#label |
Flavivirus genus
|
gptkbp:is_affected_by |
global warming
vector control measures |
gptkbp:is_associated_with |
public health funding
vector-borne diseases vaccine hesitancy issues co-infections neurotropic infections travel-related infections |
gptkbp:is_characterized_by |
icosahedral symmetry
enveloped virions |
gptkbp:is_essential_for |
public health
vaccine strategies |
gptkbp:is_found_in |
tropical and subtropical regions
|
gptkbp:is_involved_in |
host immune response
community health education vector ecology studies disease surveillance programs transmission cycles |
gptkbp:is_known_for |
high mutation rates
|
gptkbp:is_linked_to |
climate change effects
public health policies global health initiatives healthcare access issues |
gptkbp:is_monitored_by |
emerging infectious diseases
|
gptkbp:is_part_of |
gptkb:family_Flaviviridae
|
gptkbp:is_related_to |
arboviruses
other viruses in Flaviviridae |
gptkbp:is_studied_in |
gptkb:hospital
genetic diversity vaccine efficacy vaccine development transmission dynamics molecular epidemiology pathogenesis mechanisms |
gptkbp:is_vulnerable_to |
gptkb:yellow_fever
gptkb:Zika_virus_disease gptkb:West_Nile_virus_infection dengue fever |
gptkbp:issues |
travelers to endemic areas
|
gptkbp:range |
gptkb:bird
gptkb:Person primates |
gptkbp:scientific_classification |
order Amarillovirales
several serocomplexes |
gptkbp:senses |
single-stranded RNA genome
|
gptkbp:subject |
clinical trials
biomedical research international health regulations |
gptkbp:targets |
antiviral drug development
|